dpp 4 and glp 1 together Dipeptidyl Peptidase Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus - Aloke - 2025 - Pharmacoepidemiology Drug Safety Incretin axis and incretin-based therapies:

Common side effects include: Nausea Vomiting Diarrhea Stomach pain Constipation Reduced appetite More serious risks may involve: Thyroid concerns Pancreatitis Gallbladder issues Vision changes Severe gastrointestinal (GI) complications Allergic reactions A healthcare provider should review your medical history before starting treatment

Storage after reconstitution: TB-500 should be stored refrigerated and used within the stability window specified by the compounding pharmacy

doi:10.1046/j.1524-475X.1994.20406.x 9

JACC Basic Transl Sci 7(7):713715

Significantly up- or downregulated proteins between the conditions were determined by ANOVA (FDR 0.025)